July | 2018 | Discovery MS

Jul 05 2018

Spring into Science 2018

By dhmriadmin | Our Research Featured News | No Comments

“Modifiable factors are things we can change, and therefore research on these agents is exceptionally important and particularly of interest to everyone affected by chronic conditions – we all want to…

Living with MS

News & Updates

MS is an autoimmune disease, the most common neurological disease of young adults. It damages neurons in the brain and spinal cord (the central nervous system).

MS affects 400,000 individuals in the U.S and 2.5 million worldwide.

Although substantial advances have been made in the development of therapeutic treatments, the drugs currently available to MS patients do not significantly alter the long-term prognosis of the disease. Better markers that represent the biological activity of the disease process and the response to therapy are desperately needed, as are novel therapies that halt disease progression rather than just modify it.

Thank you for your interest in Discovery MS.
We look forward to speaking with you.

David H. Murdock Research Institute
150 Research Campus Drive
Kannapolis, NC 28081
discoveryms@dhmri.org

July 2018

Spring into Science 2018

Categories

Archives